Skip to content

Asia Pacific Menopause Federation Menopause Consensus

An Expert Panel Consensus Statement on the Management of Menopause in the Asia-Pacific Using Modified Delphi Methodology

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06048965
Enrollment
100
Registered
2023-09-21
Start date
2023-11-20
Completion date
2025-03-15
Last updated
2023-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause, Menopause Related Conditions

Brief summary

The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific

Detailed description

The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific. The experience of the menopause is deeply rooted in sociocultural perceptions unique to each population. Thus, the management of menopausal symptoms and other conditions related to the menopause also vary from region to region. The investigators will use a modified Delphi method involving the participation of experts from various countries in the Asia-Pacific. The objective of this study is to achieve consensus on various aspects of the management of the menopause in the Asia-Pacific. This study will involve several rounds of Delphi surveys, administered via Google Forms, Microsoft Word or PDF. Each survey questionnaire contains 1. Questions on basic demographic information 2. Statements on areas of concern in the management of the menopause; each participants vote on to what extent they agree or disagree with the statement on a Likert scale. 3. Questions on the participants' usual clinical practice in treating menopause Multiple survey rounds will be held until agreement on the statements and stability is achieved.

Interventions

OTHERNo intervention to be performed

No intervention to be performed. Anonymous survey only.

Sponsors

Singapore General Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Experience in treating menopause

Design outcomes

Primary

MeasureTime frame
Percentage of participants who vote for the same option on a series of survey questions2023-2024

Countries

Singapore

Contacts

Primary ContactFelicia Tan, MB BChir
felicia.clara.tan@gmail.com82511939

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026